GLP-2 10mg — Glucagon-Like Peptide-2 intestinotrophic research peptide (CAS 106612-94-6). GLP-2R agonist. 99% purity, USA domestic. Same-day shipping. Free shipping over $200.
$64.99
82 in stock
GLP-2 10mg is a research-grade synthetic Glucagon-Like Peptide-2 (CAS 106612-94-6), a 33-amino acid intestinotrophic hormone co-secreted with GLP-1 from intestinal L-cells in response to nutrient ingestion. GLP-2 activates the GLP-2 receptor (GLP-2R), expressed primarily in intestinal epithelium, enteric neurons, and subepithelial myofibroblasts, driving gut mucosal growth, barrier integrity, and nutrient absorption. The FDA-approved GLP-2 analog teduglutide (Gattex®) validates the clinical significance of GLP-2R signaling. The 10mg vial suits pilot studies, receptor binding assays, and protocol validation for GLP-2 pathway research.
GLP-2 10mg (CAS 106612-94-6) is used in professional pre-clinical research for:
When searching for GLP-2 10mg for sale or a trusted source to buy GLP-2 research peptide online, researchers choose Combat Research:
| Property | Value |
|---|---|
| CAS Number | 106612-94-6 |
| Also Known As | GLP-2, Glucagon-Like Peptide-2, Proglucagon (126-158) |
| Amino Acids | 33 |
| Receptor Target | GLP-2R (Glucagon-Like Peptide-2 Receptor) |
| FDA Analog | Teduglutide (Gattex®) for short bowel syndrome |
| Form | Lyophilized Powder |
| Vial Size | 10mg |
| Purity | ≥99% |
| Storage | Refrigerated, protected from light and moisture |
GLP-2 10mg is supplied as a lyophilized powder. Reconstitute with bacteriostatic water or sterile saline under aseptic conditions. Store refrigerated at 2–8°C. Minimize freeze-thaw cycles.
GLP-2 (CAS 106612-94-6) is sold exclusively for pre-clinical and in vitro laboratory research. Not for human or animal consumption. All use must comply with applicable regulations.
GLP-2 (CAS 106612-94-6) is a 33-amino acid intestinotrophic hormone co-secreted with GLP-1 from intestinal L-cells. It activates the GLP-2 receptor (GLP-2R) to promote gut mucosal growth, barrier integrity, nutrient absorption, and enterocyte survival. The FDA-approved analog teduglutide (Gattex) validates its clinical significance.
GLP-2 is studied for intestinal epithelial proliferation and crypt-villus architecture, gut barrier tight junction modulation, short bowel syndrome and intestinal adaptation models, inflammatory bowel disease repair research, nutrient malabsorption studies, and GLP-2R receptor pharmacology.
CAS 106612-94-6. GLP-2 is a 33-amino acid peptide also known as Proglucagon(126-158). The FDA-approved GLP-2 analog teduglutide (Gattex) confirms the pathway’s therapeutic significance. PubChem CID: 56841553.
GLP-1 activates GLP-1R to stimulate insulin secretion and suppress appetite – a metabolic and anti-obesity target. GLP-2 activates GLP-2R to promote intestinal growth and gut barrier integrity – an intestinotrophic and mucosal repair target. They are co-secreted from the same L-cells but have distinct receptor targets and research applications.
Yes. Teduglutide (Gattex) is an FDA-approved GLP-2 analog for short bowel syndrome (SBS). The research peptide GLP-2 (CAS 106612-94-6) is the native sequence used in pre-clinical studies investigating GLP-2R pathways and intestinal biology.
Reconstitute GLP-2 with bacteriostatic water or sterile saline under aseptic conditions. Gently swirl until dissolved. Store at 2-8 degrees Celsius refrigerated. Minimize freeze-thaw cycles to preserve peptide integrity.
GLP-2 10mg is ideal for pilot GLP-2R binding studies, intestinal epithelial proliferation assays, initial dose-response development, and protocol validation before committing to higher-volume research programs.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.